https://www.onhealthcare.tech/p/how-the-coinbase-founders-31b-longevity-364Thoughts on Healthcare Markets & Technologyen2026-06-09T13:25:24+00:00How the Coinbase Founder’s $3.1B Longevity Biotech NewLimit Chose the Most Boring Path in Medicine. What That Means for Peptide & Wellness Bros Dragging Cutting-Edge Longevity Into Reimbursed Healthhttps://www.onhealthcare.tech/p/how-the-coinbase-founders-31b-longevityThoughts on Healthcare Markets & Technologyen2026-06-09T13:19:35+00:00How the Coinbase Founder’s $3.1B Longevity Biotech NewLimit Chose the Most Boring Path in Medicine.What That Means for Peptide & Wellness Bros Dragging Cutting-Edge Longevity Into Reimbursed Healthhttps://www.onhealthcare.tech/p/lassies-47m-a16z-round-and-the-bet-1d2Thoughts on Healthcare Markets & Technologyen2026-06-08T12:46:33+00:00Lassie’s $47M a16z Round And The Bet That Autonomous AI Can Replace The Dental Front Desk: Why Sitting In A Back Office Posting 837D Claims By Hand Became A Service-As-Software Wedge Into Health Adminhttps://www.onhealthcare.tech/p/lassies-47m-a16z-round-and-the-betThoughts on Healthcare Markets & Technologyen2026-06-08T12:31:59+00:00Lassie’s $47M a16z Round And The Bet That Autonomous AI Can Replace The Dental Front Desk: Why Sitting In A Back Office Posting 837D Claims By Hand Became A Service-As-Software Wedge Into Healthcare